Why Advancing Inclusive Research Matters

Eligibility Questionnaire

We are looking for people to actively help advance the treatment of RMS. Please answer the questions below to see if you may be eligible for the FENhance Study.

Completing this questionnaire does not obligate you to participate in the study. Your answers will help determine if you may be eligible. If your answers indicate you may be eligible, you will have the opportunity to contact a clinic site near you to learn more about the study.

1. Have you been diagnosed with “relapsing-remitting multiple sclerosis” or “secondary progressive multiple sclerosis with relapses”?(Required)
3. Do you need to use an assistive device like a cane, crutch, or walker to walk 100 meters/109 yards?(Required)
4. Have you been treated with Ocrevus (ocrelizumab), Rituxan/Ruxience/Truxima (rituximab), or Kesimpta/Arzerra (ofatumumab) in the last 2 years?(Required)
5. Have you ever been treated with Cytoxan (cyclophosphamide), Lemtrada (alemtuzumab), Mavenclad (cladribine), Novantrone (Mitoxantrone), or Zinbryta (daclizumab)?(Required)
6. Do any of the following apply to you? (check all that apply)(Required)